Find en forsker – Københavns Universitet

Videresend til en ven Resize Print Bookmark and Share

Find en forsker

CNS hypoxia is more pronounced in murine cerebral than noncerebral malaria and is reversed by erythropoietin

Publikation: Forskning - peer reviewTidsskriftartikel

Casper Hempel, Valery Combes, Nicholas Henry Hunt, Jørgen Anders Lindholm Kurtzhals, Georges Emile Raymond Grau

Cerebral malaria (CM) is associated with high mortality and risk of sequelae, and development of adjunct therapies is hampered by limited knowledge of its pathogenesis. To assess the role of cerebral hypoxia, we used two experimental models of CM, Plasmodium berghei ANKA in CBA and C57BL/6 mice, and two models of malaria without neurologic signs, P. berghei K173 in CBA mice and P. berghei ANKA in BALB/c mice. Hypoxia was demonstrated in brain sections using intravenous pimonidazole and staining with hypoxia-inducible factor-1a-specific antibody. Cytopathic hypoxia was studied using poly (ADP-ribose) polymerase-1 (PARP-1) gene knockout mice. The effect of erythropoietin, an oxygen-sensitive cytokine that mediates protection against CM, on cerebral hypoxia was studied in C57BL/6 mice. Numerous hypoxic foci of neurons and glial cells were observed in mice with CM. Substantially fewer and smaller foci were observed in mice without CM, and hypoxia seemed to be confined to neuronal cell somas. PARP-1-deficient mice were not protected against CM, which argues against a role for cytopathic hypoxia. Erythropoietin therapy reversed the development of CM and substantially reduced the degree of neural hypoxia. These findings demonstrate cerebral hypoxia in malaria, strongly associated with cerebral dysfunction and a possible target for adjunctive therapy.
OriginalsprogEngelsk
TidsskriftAmerican Journal of Pathology
Vol/bind179
Tidsskriftsnummer4
Sider (fra-til)1939-50
Antal sider12
ISSN0002-9440
DOI
StatusUdgivet - 1 okt. 2011

ID: 35276863